Next, four weeks after MCT treatment, we isolated CD11c+ tumor-infiltrating DCs (TIL DCs) or E0771-Ova tumor-draining lymph node derived DCs (LN-DCs) and co-cultured them with total CD3+ OT-I T cells. The gene discussed is ITGAX; the disease is neoplasm.